Denosumab - Latest Advances

Refractory hypercalcemic crisis: A case of primary hyperparathyroidism with Gitelman syndrome.

Journal: The Journal of international medical research

Published: December 09, 2025

Proton Pump Inhibitors Are Associated With Increased Risk of Site-Specific Nonunion After Open Reduction Internal Fixation.

Journal: Journal of orthopaedic trauma

Published: December 09, 2025

Pediatric Giant-Cell Tumor of Bone With Secondary Aneurysmal Bone Cyst Causing Orbital Apex Syndrome.

Journal: Journal of pediatric ophthalmology and strabismus

Published: December 08, 2025

How to optimize the use of anti-osteoporotic medication in clinical practice?

Journal: Expert opinion on pharmacotherapy

Published: December 06, 2025

Bone Disease in Primary Hyperparathyroidism.

Journal: Journal of musculoskeletal & neuronal interactions

Published: December 01, 2025

The preclinical discovery and development of romosozumab for the treatment of people with severe osteoporosis who are at high risk of fracture.

Journal: Expert opinion on drug discovery

Published: November 24, 2025

Bone modifying agents and multikinase inhibitors as treatments for chordoma: A TriNetX-based retrospective cohort study.

Journal: Clinical neurology and neurosurgery

Published: November 23, 2025

A Novel Approach to the Treatment of Familial Expansile Osteolysis: A Rare Genetic Bone Pathology: A Case Report.

Journal: JBJS case connector

Published: November 20, 2025

A budget impact model for biosimilar denosumab for skeletal-related events and fractures in the United States oncology population.

Journal: Journal of medical economics

Published: November 19, 2025

Sequence treatment of postmenopausal osteoporosis

Journal: Ugeskrift for laeger

Published: November 18, 2025

Recent Advances in Osteoporosis Therapeutics.

Journal: Annual review of medicine

Published: November 18, 2025

Adherence to denosumab therapy and fracture risk associated with drug withdrawal: a retrospective study.

Journal: Croatian medical journal

Published: November 07, 2025

Filters

Refractory hypercalcemic crisis: A case of primary hyperparathyroidism with Gitelman syndrome.

Refractory hypercalcemic crisis: A case of primary hyperparathyroidism with Gitelman syndrome.

Proton Pump Inhibitors Are Associated With Increased Risk of Site-Specific Nonunion After Open Reduction Internal Fixation.

Proton Pump Inhibitors Are Associated With Increased Risk of Site-Specific Nonunion After Open Reduction Internal Fixation.

Pediatric Giant-Cell Tumor of Bone With Secondary Aneurysmal Bone Cyst Causing Orbital Apex Syndrome.

Pediatric Giant-Cell Tumor of Bone With Secondary Aneurysmal Bone Cyst Causing Orbital Apex Syndrome.

How to optimize the use of anti-osteoporotic medication in clinical practice?

How to optimize the use of anti-osteoporotic medication in clinical practice?

Bone Disease in Primary Hyperparathyroidism.

Bone Disease in Primary Hyperparathyroidism.

The preclinical discovery and development of romosozumab for the treatment of people with severe osteoporosis who are at high risk of fracture.

The preclinical discovery and development of romosozumab for the treatment of people with severe osteoporosis who are at high risk of fracture.

Bone modifying agents and multikinase inhibitors as treatments for chordoma: A TriNetX-based retrospective cohort study.

Bone modifying agents and multikinase inhibitors as treatments for chordoma: A TriNetX-based retrospective cohort study.

A Novel Approach to the Treatment of Familial Expansile Osteolysis: A Rare Genetic Bone Pathology: A Case Report.

A Novel Approach to the Treatment of Familial Expansile Osteolysis: A Rare Genetic Bone Pathology: A Case Report.

A budget impact model for biosimilar denosumab for skeletal-related events and fractures in the United States oncology population.

A budget impact model for biosimilar denosumab for skeletal-related events and fractures in the United States oncology population.

Sequence treatment of postmenopausal osteoporosis

Sequence treatment of postmenopausal osteoporosis

Recent Advances in Osteoporosis Therapeutics.

Recent Advances in Osteoporosis Therapeutics.

Adherence to denosumab therapy and fracture risk associated with drug withdrawal: a retrospective study.

Adherence to denosumab therapy and fracture risk associated with drug withdrawal: a retrospective study.